Yunfeng Fu

2.9k total citations
102 papers, 2.2k citations indexed

About

Yunfeng Fu is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Yunfeng Fu has authored 102 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 25 papers in Epidemiology and 25 papers in Cancer Research. Recurrent topics in Yunfeng Fu's work include Cervical Cancer and HPV Research (13 papers), MicroRNA in disease regulation (13 papers) and Cancer-related molecular mechanisms research (13 papers). Yunfeng Fu is often cited by papers focused on Cervical Cancer and HPV Research (13 papers), MicroRNA in disease regulation (13 papers) and Cancer-related molecular mechanisms research (13 papers). Yunfeng Fu collaborates with scholars based in China, United States and Hong Kong. Yunfeng Fu's co-authors include Yan Xiong, Yanwei Luo, Meng Gao, Xing Xie, Rong Gui, Weiguo Lü, Wei Tang, Jing Liu, Jianping Zuo and Yifu Yang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yunfeng Fu

98 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunfeng Fu China 27 1.2k 774 318 281 264 102 2.2k
Ji Zhang China 26 1.5k 1.3× 654 0.8× 370 1.2× 358 1.3× 256 1.0× 112 2.5k
Meng Xia China 26 1.3k 1.1× 507 0.7× 309 1.0× 397 1.4× 314 1.2× 93 2.3k
Dongshan Zhang China 28 1.3k 1.1× 714 0.9× 407 1.3× 193 0.7× 385 1.5× 77 2.9k
Shuai Zhang China 30 1.3k 1.1× 830 1.1× 233 0.7× 491 1.7× 237 0.9× 183 2.7k
Jie Tang China 26 1.3k 1.1× 795 1.0× 142 0.4× 356 1.3× 212 0.8× 120 2.2k
Wenshu Chen China 27 1.2k 1.0× 540 0.7× 320 1.0× 350 1.2× 634 2.4× 82 2.3k
Yan Xie China 25 1.3k 1.1× 556 0.7× 167 0.5× 301 1.1× 290 1.1× 93 2.5k
Min Feng China 29 1.6k 1.3× 887 1.1× 285 0.9× 626 2.2× 391 1.5× 112 2.9k
Kohei Taniguchi Japan 26 1.5k 1.3× 1.2k 1.5× 261 0.8× 367 1.3× 220 0.8× 153 2.5k
Guisheng Qian China 25 1.2k 1.0× 506 0.7× 215 0.7× 393 1.4× 308 1.2× 96 2.2k

Countries citing papers authored by Yunfeng Fu

Since Specialization
Citations

This map shows the geographic impact of Yunfeng Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunfeng Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunfeng Fu more than expected).

Fields of papers citing papers by Yunfeng Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunfeng Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunfeng Fu. The network helps show where Yunfeng Fu may publish in the future.

Co-authorship network of co-authors of Yunfeng Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Yunfeng Fu. A scholar is included among the top collaborators of Yunfeng Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunfeng Fu. Yunfeng Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Yunfeng, et al.. (2025). UBE4B promotes gastric cancer proliferation and metastasis by mediating FAT4 ubiquitination and degradation. Cell Death and Disease. 16(1). 551–551.
2.
Wang, Yuehan, Qianqian Wu, Xiao-Fei Zhang, et al.. (2025). Risk-based triage strategy by extended HPV genotyping for women with ASC-US cytology. Annals of Medicine. 57(1). 2451183–2451183. 1 indexed citations
3.
He, Zhijie, Chao Zhao, Qi Zhu, et al.. (2025). Construction and validation of a nomogram based on the log odds of positive lymph nodes to predict the prognosis of T1 gastric cancer. Scientific Reports. 15(1). 7788–7788.
5.
Li, Fangfang, et al.. (2024). scRNA-Seq and Bulk-Seq Analysis Identifies S100A9 Plasma Cells as a Potentially Effective Immunotherapeutic Agent for Multiple Myeloma. Journal of Inflammation Research. Volume 17. 1527–1548. 1 indexed citations
6.
Chen, Shumei, et al.. (2023). Digital evaluation of planetary concrete mixer efficiency. Automation in Construction. 150. 104834–104834. 5 indexed citations
7.
Xu, Yongjun, Yunfeng Fu, Linlin Cui, et al.. (2023). Proteomics analyses of acute kidney injury biomarkers in a rat exertional heat stroke model. Frontiers in Physiology. 14. 1176998–1176998. 6 indexed citations
8.
Xu, Cong, Meng Gao, Junhua Zhang, & Yunfeng Fu. (2023). IL5RA as an immunogenic cell death-related predictor in progression and therapeutic response of multiple myeloma. Scientific Reports. 13(1). 8528–8528. 9 indexed citations
9.
Ye, Lele, et al.. (2023). Radical Hysterectomy With Preoperative Conization in Early-Stage Cervical Cancer: A Systematic Review and Pairwise and Network Meta-Analysis. Journal of Minimally Invasive Gynecology. 31(3). 193–199. 2 indexed citations
10.
Yang, Qin, Siyi Jiang, Qiangqiang Zhao, et al.. (2023). CD38-targeted and erythrocyte membrane camouflaged nanodrug delivery system for photothermal and chemotherapy in multiple myeloma. International Journal of Pharmaceutics. 643. 123241–123241. 10 indexed citations
11.
Zhang, Yongnu, Chunyu Huang, Ruochun Lian, et al.. (2021). The low cytotoxic activity of peripheral blood NK cells may relate to unexplained recurrent miscarriage. American Journal of Reproductive Immunology. 85(6). e13388–e13388. 14 indexed citations
12.
Luo, Yanwei, et al.. (2020). A novel epigenetic regulation of circFoxp1 on Foxp1 in colon cancer cells. Cell Death and Disease. 11(9). 782–782. 18 indexed citations
13.
Ren, Qun, Rong Lin, Lei Yan, et al.. (2019). <p>Integrative gene expression profiling reveals that dysregulated triple microRNAs confer paclitaxel resistance in non-small cell lung cancer via co-targeting MAPT</p>. Cancer Management and Research. Volume 11. 7391–7404. 11 indexed citations
14.
Gao, Meng, Chengyuan Li, Han Xiao, et al.. (2019). hsa_circ_0007841: A Novel Potential Biomarker and Drug Resistance for Multiple Myeloma. Frontiers in Oncology. 9. 1261–1261. 46 indexed citations
15.
Gui, Rong, Hao Tang, Meng Gao, et al.. (2017). Impact of perioperative blood transfusion on survival of patients undergoing laparoscopic gastrectomy for gastric cancer.. PubMed. 22(2). 396–402. 4 indexed citations
16.
Xu, Lin, Yanan Zhang, Meng Gao, Guangping Wang, & Yunfeng Fu. (2016). Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells. Biochemical and Biophysical Research Communications. 472(4). 662–668. 12 indexed citations
17.
Fu, Yunfeng, et al.. (2015). Residual disease and risk factors in patients with high-grade cervical intraepithelial neoplasia and positive margins after initial conization. Therapeutics and Clinical Risk Management. 11. 851–851. 17 indexed citations
18.
Fu, Yunfeng, et al.. (2011). Overexpression of Glycogen Synthase Kinase-3 in Ovarian Carcinoma Cells With Acquired Paclitaxel Resistance. International Journal of Gynecological Cancer. 21(3). 439–444. 36 indexed citations
19.
Zhu, Yina, Yifu Yang, Yunfeng Fu, et al.. (2006). Periplocoside E Inhibits Experimental Allergic Encephalomyelitis by Suppressing Interleukin 12-Dependent CCR5 Expression and Interferon-γ-Dependent CXCR3 Expression in T Lymphocytes. Journal of Pharmacology and Experimental Therapeutics. 318(3). 1153–1162. 25 indexed citations
20.
Fu, Yunfeng, Yan Xiong, & Zheng Guo. (2005). A reduction of endogenous asymmetric dimethylarginine contributes to the effect of captopril on endothelial dysfunction induced by homocysteine in rats. European Journal of Pharmacology. 508(1-3). 167–175. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026